Product Information

DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.9216 per EA under NDC 75834026460. Its NADAC has been published 218 times since Sep 21, 2022.

FDA first approved this application on Feb 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET

diclofenac sodium and misoprostol
$0.9216per EA

Strength

50; 200 mg/1; ug/1

NDC

75834026460

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205143

FDA Approved

2/19/2020

TE Code

AB

On Market Since

7/15/2021

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Prostaglandin E1 Analog
Prostaglandins E
Synthetic

Price Statistics

The NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has been published 218 times since Sep 21, 2022, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9216 per EA
All-time high$1.5755 (Apr 10, 2024)
All-time low$0.6645 (Sep 23, 2026)
52-week high$1.0044
52-week low$0.6645
Median price$0.9845
Average price$0.9842
Largest weekly change+59.0% (Mar 20, 2024)
Weeks tracked218
Tracking sinceSep 21, 2022

Price History

1W

+18.9%

1M

+38.7%

3M

+34.2%

6M

-2.1%

1Y

+1.9%

3Y

-14.9%

5Y

N/A

All

-28.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.9216 per EA (NDC 75834026460), effective Nov 18, 2026.

How has the price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET changed over time?

Over the history we have for it, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has declined 28.7%. It has been tracked across 218 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?

Since Sep 21, 2022, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has ranged from a low of $0.6645 (Sep 23, 2026) to a high of $1.5755 (Apr 10, 2024), with a median of $0.9845 per EA.

Are there cheaper alternatives to DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?

DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET (NDC 75834026460) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.